Table 2.
Cancer-specific survival in long-term survivors (n = 119)
| Variable | Total (n) |
Alive or censored % (n) |
Dead from CRC % (n) |
P value | |
|---|---|---|---|---|---|
| Age | <65 years | 62 | 80.6 % (50) | 16.1 % (10) | 0.197 |
| ≥65 years | 57 | 63.2 % (36) | 7.0 % (4) | ||
| Gender | Male | 73 | 65.8 % (48) | 16.4 % (12) | 0.041 |
| Female | 46 | 82.6 % (38) | 4.3 % (2) | ||
| TNM stage | I + II | 93 | 77.4 % (72) | 7.5 % (7) | 0.002 |
| III | 26 | 53.8 % (14) | 26.9 % (7) | ||
| Location | Distal | 83 | 71.1 % (59) | 10.8 % (9) | 0.664 |
| Proximal | 36 | 75.0 % (27) | 13.9 % (5) | ||
| Location | Colon | 73 | 79.5 % (58) | 8.2 % (6) | 0.113 |
| Rectum | 46 | 60.9 % (28) | 17.4 % (8) | ||
| MSI status | MSI | 25 | 84.0 % (21) | 8.0 % (2) | 0.483 |
| MSS | 94 | 69.1 % (65) | 12.8 % (12) | ||
| Grade | High/moderate | 108 | 70.4 % (76) | 13.0 % (14) | 0.233 |
| Low/mucinous | 11 | 90.9 % (10) | 0 | ||
| T stage | 1 + 2 | 27 | 70.4 % (19) | 11.1 % (3) | 0.892 |
| 3 + 4 | 92 | 72.8 % (67) | 12.0 % (11) |